Among the seven genes, expression levels of APH1B increased in the blood of AD patients and were associated with entorhinal cortical thickness; global cortical amyloid deposition; several plasma-based protein levels, including growth hormone receptors; and progression from MCI to AD dementia. Here, GHR is linked to amyloidosis.